Publication:
The utility of ga-68-psma pet/ct in poorly differentiated metastatic prostate cancer

Placeholder

Organizational Units

Program

KU Authors

Co-Authors

Uçar, Burcu
Sağlıcan, Yeşim

Advisor

Publication Date

2017

Language

English

Type

Other

Journal Title

Journal ISSN

Volume Title

Abstract

We aimed to emphasize how useful PSMA PET/CT findings can be while trying to restage prostate cancer after radical prostatectomy in the presence of low prostate-specific antigen values. A 64-year-old man with pT3b N1 M0 Gleason 7 adenocarcinoma of the prostate presented 5 years postoperatively with a palpable axillary mass, whereas his prostate-specific antigen was 0.08 ng/mL. Conventional imaging studies and histopathologic findings of the axillary mass biopsy revealed inconclusive results. Ga-68-PSMA PET/CT demonstrated PSMA-positive metastatic lesions, the largest one being located in the right axilla. This finding confirmed metastatic poorly differentiated prostate cancer, and androgen deprivation therapy was initiated.

Description

Source:

Clinical Nuclear Medicine

Publisher:

Lippincott Williams & Wilkins

Keywords:

Subject

Radiology, Nuclear medicine, Medical imaging

Citation

Endorsement

Review

Supplemented By

Referenced By

Copy Rights Note

1

Views

0

Downloads

View PlumX Details